Tanja Busk Bidstrup

CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.

I. Bjørnsdottir, M. Thomsen, Tanja Busk Bidstrup, 2003, British journal of clinical pharmacology.

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

K. Brøsen, P. Damkier, M. Thomsen, 2004, European Journal of Clinical Pharmacology.

The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide.

K. Brøsen, P. Damkier, Tanja Busk Bidstrup, 2006, British journal of clinical pharmacology.

Review of recent reported clinical effects of ginseng. Dias report

L. P. Christensen, K. Kristiansen, K. Brøsen, 2006 .

The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers

F. Nielsen, K. Brøsen, R. Pedersen, 2006, European Journal of Clinical Pharmacology.

PHARMACOKINETICS A ND D ISPOSITION

K. Brøsen, P. Damkier, Tanja Busk Bidstrup, 2004 .